{"content":"<li class=\"n-box-item date-title\" data-end=\"1531195199\" data-start=\"1531108800\" data-txt=\"Monday, December 23, 2019\">Monday, July  9, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3368783\" data-ts=\"1531192522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YAHOY\" target=\"_blank\">YAHOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368783-yahoo-japan-plans-buyback-in-three-way-deal-altaba-softbank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yahoo Japan plans buyback in three-way deal with Altaba, SoftBank</a></h4><ul>   <li>Yahoo Japan (<a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a>) will <a href=\"https://www.reuters.com/article/uk-softbank-group-yahoo-japan-altaba/softbank-to-buy-2-billion-of-yahoo-japan-shares-held-by-altaba-idUKKBN1JZ2WE\" target=\"_blank\">buy back about $2B worth of its shares</a> in a three-way deal with top shareholders SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) and Altaba (NASDAQ:<a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a>), the former Yahoo.</li>    <li>That's slightly more than the amount Yahoo Japan was <a href=\"https://seekingalpha.com/news/3368695-yahoo-japan-mulls-buyback-ease-altaba-stake-sale\" target=\"_blank\">reportedly considering -- &yen;200B worth</a>, about $1.8B.</li>    <li>Yahoo Japan will buy the shares from SoftBank Group. SoftBank in turn will see its stake in Yahoo Japan rise to about 48%, and Altaba will sell down its stake by about $2B (leaving it with about 27%).</li>    <li>That will happen via SoftBank buying &yen;221B of Yahoo Japan shares from Altaba through a tender offer at Monday's closing price, followed by Yahoo Japan buying &yen;220B worth from SoftBank.</li>    <li>In Tokyo now: SoftBank <font color='green'>up 2.1%</font>; Yahoo Japan <font color='green'>up 11.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368783\" data-linked=\"Yahoo Japan plans buyback in three-way deal with Altaba, SoftBank\" data-tweet=\"$YAHOY $YAHOY $SFTBY - Yahoo Japan plans buyback in three-way deal with Altaba, SoftBank https://seekingalpha.com/news/3368783-yahoo-japan-plans-buyback-in-three-way-deal-altaba-softbank?source=tweet\" data-url=\"https://seekingalpha.com/news/3368783-yahoo-japan-plans-buyback-in-three-way-deal-altaba-softbank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368779\" data-ts=\"1531176950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368779-adamis-pharma-files-for-150m-mixed-shelf-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamis Pharma files for $150M mixed shelf offering; shares down 4% after hours</a></h4><ul><li>Adamis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/887247/000138713118003074/admp-s3_123117.htm\" target=\"_blank\">prospectus </a>for a $150M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368779\" data-linked=\"Adamis Pharma files for $150M mixed shelf offering; shares down 4% after hours\" data-tweet=\"$ADMP - Adamis Pharma files for $150M mixed shelf offering; shares down 4% after hours https://seekingalpha.com/news/3368779-adamis-pharma-files-for-150m-mixed-shelf-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3368779-adamis-pharma-files-for-150m-mixed-shelf-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368774\" data-ts=\"1531176368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368774-jpmorgan-buy-twitters-dip-after-confusing-account-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan: Buy Twitter&#39;s dip after confusing account report</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) ended up mitigating the <a href=\"https://seekingalpha.com/news/3368636-twitter-minus-8_4-percent-report-mass-suspensions\" target=\"_blank\">biggest part of its decline today</a> spurred by a <a href=\"https://seekingalpha.com/news/3368452-post-twitter-suspension-pace-hit-user-growth\" target=\"_blank\">Friday report about user account suspensions</a>, and JPMorgan for one said to buy the dip.</li>    <li>\"We'd be taking advantage of the weakness,\" say analyst Doug Anmuth, who says a Washington Post report sowed \"confusion\" about whether removing 70M fake accounts would hit user numbers to be reported later this month. (h/t Bloomberg)</li>    <li>Improving quality is critical for service health, he writes (there he's in <a href=\"https://seekingalpha.com/news/3368700-twitter-pares-losses-cfo-comments-user-metrics\" target=\"_blank\">agreement with CFO Ned Segal</a>); and he believes a significant number of the suspended accounts were dormant more than 30 days and therefore don't end up as monthly active users.</li>    <li>He still expects 2M net adds for Twiter's MAUs in a seasonally light quarter, vs. zero adds a year ago (and 6M net adds in Q1).</li>    <li>The firm has a $50 price target, implying 13% upside from today's close. Shares closed <font color='red'>down 5.4%</font> today and are ticking <font color='green'>up 0.1%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368774\" data-linked=\"JPMorgan: Buy Twitter&#39;s dip after confusing account report\" data-tweet=\"$TWTR - JPMorgan: Buy Twitter&#39;s dip after confusing account report https://seekingalpha.com/news/3368774-jpmorgan-buy-twitters-dip-after-confusing-account-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3368774-jpmorgan-buy-twitters-dip-after-confusing-account-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368772\" data-ts=\"1531175253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHD\" target=\"_blank\">WHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368772-cactus-plans-10m-share-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cactus plans 10M-share public offering</a></h4><ul>     <li>Cactus (NYSE:<a href='https://seekingalpha.com/symbol/WHD' title='Cactus, Inc.'>WHD</a>) <font color='red'>-5.7%</font> after-hours on news it has commenced a <a href=\"https://seekingalpha.com/pr/17210940-cactus-announces-public-offering-common-stock\" target=\"_blank\">public offering</a> of 10M common shares, with an underwriters option to purchase as much as 1.5M additional shares.</li>     <li>WHD says it plans to contribute the proceeds to its       Cactus Wellhead subsidiary in exchange for common units representing limited liability company interests in Cactus LLC.</li>     <li>WHD also <a href=\"https://www.sec.gov/Archives/edgar/data/1699136/000110465918044311/a18-11077_8ex99d1.htm\" target=\"_blank\">estimates</a> revenues for its June quarter will total $136M-$139M vs. $82M for last year's June quarter, with net income of $40.6M-$42.4M vs. $16.6M in the year-ago quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368772\" data-linked=\"Cactus plans 10M-share public offering\" data-tweet=\"$WHD - Cactus plans 10M-share public offering https://seekingalpha.com/news/3368772-cactus-plans-10m-share-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3368772-cactus-plans-10m-share-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368769\" data-ts=\"1531174341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISR\" target=\"_blank\">ISR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368769-isorayplus-143-after-fda-clears-brachytherapy-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IsoRay +143% after FDA clears brachytherapy technology</a></h4><ul>     <li>IsoRay (NYSEMKT:<a href='https://seekingalpha.com/symbol/ISR' title='IsoRay, Inc.'>ISR</a>) more than doubled in today's trade and <font color='green'>+12%</font> after-hours on news that the <a href=\"https://seekingalpha.com/pr/17210758-isoray-announces-fda-clearance-gammatile-therapy-treatment-recurrent-brain-neoplasms\" target=\"_blank\">Food and Drug Administration cleared</a> its GammaTile therapy for treatment of recurrent brain tumors.</li>     <li>ISR says its GammaTile therapy leverages Cesium-131&rsquo;s ability to deliver a highly targeted dose of intense radiation treatment while limiting radiation exposure to surrounding tissue.</li>     <li>The Centers for Medicare and Medicaid Services already clarified the coding for GammaTile in the hospital setting by assigning GammaTile therapy to a new, specific ICD-10-PCS code; now that the FDA has issued regulatory clearance, ISR says the therapy can be made available in the near future to patients served by hospitals throughout the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368769\" data-linked=\"IsoRay +143% after FDA clears brachytherapy technology\" data-tweet=\"$ISR - IsoRay +143% after FDA clears brachytherapy technology https://seekingalpha.com/news/3368769-isorayplus-143-after-fda-clears-brachytherapy-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3368769-isorayplus-143-after-fda-clears-brachytherapy-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368762\" data-ts=\"1531172169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368762-celgene-acceleron-announce-positive-results-in-blood-disorder-drug-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene, Acceleron announce positive results in blood disorder drug study</a></h4><ul>     <li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) and Acceleron Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a>) say their jointly developed Luspatercept drug <a href=\"https://seekingalpha.com/pr/17210952-celgene-acceleron-announce-luspatercept-achieved-primary-key-secondary-endpoints-phase-iii\" target=\"_blank\">achieved primary and all key secondary endpoints</a> in a Phase 3 clinical trial for treatment of transfusion-dependent Beta-Thalassemia.</li>     <li>The companies say the drug significantly lowered the rate of transfusions needed in patients with the blood disorder where abnormal hemoglobin production causes anemia.</li>     <li>CELG&nbsp;<font color='green'>+1.7%</font>, XLRN&nbsp;<font color='green'>+11.6%</font> after-hours in response to the news.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368762\" data-linked=\"Celgene, Acceleron announce positive results in blood disorder drug study\" data-tweet=\"$CELG $CELG $XLRN - Celgene, Acceleron announce positive results in blood disorder drug study https://seekingalpha.com/news/3368762-celgene-acceleron-announce-positive-results-in-blood-disorder-drug-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3368762-celgene-acceleron-announce-positive-results-in-blood-disorder-drug-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368761\" data-ts=\"1531172121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCX\" target=\"_blank\">OCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368761-after-hours-gainers-losers-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (07/09/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>&nbsp;<font color='green'>+63.0%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a>&nbsp;<font color='green'>+7.4%</font>. <a href='https://seekingalpha.com/symbol/AMPY' title='Amplify Energy Corp.'>OTCQX:AMPY</a>&nbsp;<font color='green'>+3.3%.&nbsp;</font><a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>&nbsp;<font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+2.7%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color='red'>-5.0%</font>. <a href='https://seekingalpha.com/symbol/WHD' title='Cactus, Inc.'>WHD</a>&nbsp;<font color='red'>-4.0%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/FTD' title='FTD Companies, Inc.'>FTD</a>&nbsp;<font color='red'>-2.7%.&nbsp;</font><a href='https://seekingalpha.com/symbol/MRBK' title='Meridian Bank'>MRBK</a>&nbsp;<font color='red'>-1.4%</font>. <a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a>&nbsp;<font color='red'>-1.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368761\" data-linked=\"After Hours Gainers / Losers (07/09/2018)\" data-tweet=\"$OCX $OCX $ATEC - After Hours Gainers / Losers (07/09/2018) https://seekingalpha.com/news/3368761-after-hours-gainers-losers-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368761-after-hours-gainers-losers-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368757\" data-ts=\"1531171150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368757-gogo-slides-guggenheim-trims-estimates-ahead-of-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo slides as Guggenheim trims estimates ahead of call</a></h4><ul>   <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) finished the day <font color='red'>down 6.5%</font> -- but not before tagging an all-time low -- after Guggenheim reduced estimates, the latest blow in a tough year for the aviation connectivity provider.</li>    <li>Shares are <font color='red'>down 59.5%</font> YTD, with its biggest decline coming in the days after its earnings report in May when the company <a href=\"https://seekingalpha.com/news/3353883-gogo-decline-accelerates-continued-sell\" target=\"_blank\">pulled its annual forecasts</a>.</li>    <li>It's set to discuss a <a href=\"https://seekingalpha.com/news/3367215-gogo-sets-july-13-call-discuss-integrated-business-plan\" target=\"_blank\">new integrated business plan</a> before the market opens on Friday, with key conclusions from its review due after Thursday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368757\" data-linked=\"Gogo slides as Guggenheim trims estimates ahead of call\" data-tweet=\"$GOGO - Gogo slides as Guggenheim trims estimates ahead of call https://seekingalpha.com/news/3368757-gogo-slides-guggenheim-trims-estimates-ahead-of-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3368757-gogo-slides-guggenheim-trims-estimates-ahead-of-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368754\" data-ts=\"1531170534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368754-fang-holdings-rises-after-mou-for-10-stake-in-chongqing-wanli-new-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings rises after MoU for 10% stake in Chongqing Wanli New Energy</a></h4><ul><li>Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>)<font color='green'> rises 2.4%</font>&nbsp;in after-hours trading after announcing it's in a preliminary agreement to acquire 10% equity interest in Chongqing Wanli New Energy for 500M yuan&nbsp;(US$75.6M) cash consideration from its controlling stockholder.</li><li>As part of the non-binding memorandum, the seller agrees to purchase from Wanli its battery business for at least 680M yuan within three years after the transaction.</li><li>Wanli New Energy trades on the Shanghai Stock Exchange.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17210925-fang-signs-non-binding-memorandum-acquire-equity-interest-wanli\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3368754\" data-linked=\"Fang Holdings rises after MoU for 10% stake in Chongqing Wanli New Energy\" data-tweet=\"$SFUN - Fang Holdings rises after MoU for 10% stake in Chongqing Wanli New Energy https://seekingalpha.com/news/3368754-fang-holdings-rises-after-mou-for-10-stake-in-chongqing-wanli-new-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3368754-fang-holdings-rises-after-mou-for-10-stake-in-chongqing-wanli-new-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368749\" data-ts=\"1531169396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCX\" target=\"_blank\">OCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368749-oncocyte-reports-better-expected-results-from-lung-cancer-liquid-biopsy-test-shares-up-56\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoCyte reports better-than-expected results from lung cancer liquid biopsy test; shares up 56% after hours</a></h4><ul><li>Thinly traded micro cap OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) is up&nbsp;<font color='green'>56%</font>&nbsp;after hours on average volume in response to its <a href=\"https://seekingalpha.com/pr/17210882-oncocyte-reports-encouraging-new-study-results-lung-cancer-blood-test\" target=\"_blank\">announcement </a>that a study of its DetermaVu lung cancer test based on Next Gen Sequencing &#40;NGS&#41;, an enhanced algorithm and incorporating new biomarkers showed a level of performance beyond expectations.</li><li>The company says the use of the NGS platform may enable decentralized operations beyond its CLIA lab and the development of a CE-Mark'd test kit that could be distributed in Europe.</li><li>It plans to further test the new biomarkers on a broader set of samples aimed at selecting the best biomarker panel and algorithm. It expects to complete the expanded R&amp;D validation study by year-end and the clinical validation study in H1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368749\" data-linked=\"OncoCyte reports better-than-expected results from lung cancer liquid biopsy test; shares up 56% after hours\" data-tweet=\"$OCX - OncoCyte reports better-than-expected results from lung cancer liquid biopsy test; shares up 56% after hours https://seekingalpha.com/news/3368749-oncocyte-reports-better-expected-results-from-lung-cancer-liquid-biopsy-test-shares-up-56?source=tweet\" data-url=\"https://seekingalpha.com/news/3368749-oncocyte-reports-better-expected-results-from-lung-cancer-liquid-biopsy-test-shares-up-56\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368745\" data-ts=\"1531168359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSP\" target=\"_blank\">INSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368745-aetna-to-cover-inspire-neurostimulation-device-for-obstructive-sleep-apnea-shares-up-5-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aetna to cover Inspire neurostimulation device for obstructive sleep apnea; shares up 5% after hours</a></h4><ul><li>Thinly traded Inspire Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/INSP' title='Inspire Medical Systems, Inc.'>INSP</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;after hours in response to its <a href=\"https://seekingalpha.com/pr/17210850-inspire-medical-systems-inc-announces-aetna-coverage-inspire-therapy-treatment-obstructive\" target=\"_blank\">announcement </a>that health insurer Aetna will cover its hypoglossal nerve neurostimulation device, <a href=\"https://www.inspiresleep.com/what-is-inspire-therapy/how-inspire-therapy-works/\" target=\"_blank\">Inspire Therapy</a>, for the treatment of obstructive sleep apnea for its 22M members.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368745\" data-linked=\"Aetna to cover Inspire neurostimulation device for obstructive sleep apnea; shares up 5% after hours\" data-tweet=\"$INSP - Aetna to cover Inspire neurostimulation device for obstructive sleep apnea; shares up 5% after hours https://seekingalpha.com/news/3368745-aetna-to-cover-inspire-neurostimulation-device-for-obstructive-sleep-apnea-shares-up-5-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3368745-aetna-to-cover-inspire-neurostimulation-device-for-obstructive-sleep-apnea-shares-up-5-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368742\" data-ts=\"1531167905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPRO\" target=\"_blank\">SPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368742-spero-readies-stock-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spero readies stock offering; shares down 1% after hours</a></h4><ul><li>Spero Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a>) <a href=\"https://seekingalpha.com/pr/17210881-spero-therapeutics-announces-proposed-offering-common-stock\" target=\"_blank\">commences </a>a public offering of 4.5M shares of common stock. Underwriters over-allotment is an additional 675K shares. Price and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368742\" data-linked=\"Spero readies stock offering; shares down 1% after hours\" data-tweet=\"$SPRO - Spero readies stock offering; shares down 1% after hours https://seekingalpha.com/news/3368742-spero-readies-stock-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3368742-spero-readies-stock-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368738\" data-ts=\"1531166971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCAR\" target=\"_blank\">PCAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368738-paccar-reloads-buyback-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PACCAR reloads buyback program</a></h4><ul> <li>PACCAR (NASDAQ:<a href='https://seekingalpha.com/symbol/PCAR' title='PACCAR Inc.'>PCAR</a>) announces that its board approved the repurchase of       an additional $300M worth of stock.</li><li>The company recently completed its previously authorized $300M share       repurchase program.</li><li>&ldquo;PACCAR&rsquo;s excellent net profits and cash flow       deliver good returns for its shareholders,\" maintains Executive Chairman&nbsp;Mark Pigott. \"The company&rsquo;s shareholder return has averaged 12.5 percent in       the last fifteen years, compared to the S&amp;P 500 Index return of 9.5       percent,\" he notes.</li><li>PCAR  <font color='green'>+1.07%</font> after hours to  $62.50.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17210836-paccar-announces-300-million-share-repurchase\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3368738\" data-linked=\"PACCAR reloads buyback program\" data-tweet=\"$PCAR - PACCAR reloads buyback program https://seekingalpha.com/news/3368738-paccar-reloads-buyback-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3368738-paccar-reloads-buyback-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368731\" data-ts=\"1531166178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAF\" target=\"_blank\">STAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368731-staffing-360-skyrockets-on-huge-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Staffing 360 skyrockets on huge volume</a></h4><ul><li>Staffing 360 Solutions (<a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+282.5%</font>) makes a monster move off acquisition news from this morning.</li><li>The spike looks to be of the speculative side without a whole lot of financial details issued with the press release on the pickup of Clement May Limited.</li><li>Trading volume on the staffing stock is over 21M shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368490-staffing-360-solutions-announces-acquisition-clement-may-uk\" target=\"_blank\">Staffing 360 Solutions announces acquisition of Clement May in the UK</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368731\" data-linked=\"Staffing 360 skyrockets on huge volume\" data-tweet=\"$STAF - Staffing 360 skyrockets on huge volume https://seekingalpha.com/news/3368731-staffing-360-skyrockets-on-huge-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3368731-staffing-360-skyrockets-on-huge-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368730\" data-ts=\"1531165575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CISN\" target=\"_blank\">CISN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368730-cisionplus-3_4-rbc-starts-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cision +3.4% as RBC starts at Outperform</a></h4><ul>   <li>Cision (NYSE:<a href='https://seekingalpha.com/symbol/CISN' title='Cision Ltd.'>CISN</a>) is <font color='green'>up 3.4%</font> after a start at Outperform by RBC Capital.</li>    <li>The company owns about 20% of a $3.5B public-relations software market, Matthew Hedberg says, and he expects faster organic revenue growth from an already profitable position.</li>    <li>He has a price target of $20, implying nearly 26% further upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368730\" data-linked=\"Cision +3.4% as RBC starts at Outperform\" data-tweet=\"$CISN - Cision +3.4% as RBC starts at Outperform https://seekingalpha.com/news/3368730-cisionplus-3_4-rbc-starts-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3368730-cisionplus-3_4-rbc-starts-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368729\" data-ts=\"1531165523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368729-cytori-gives-up-early-gains-down-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori gives up early gains, down 12%</a></h4><ul><li>Thinly traded nano cap Cytori Therapeutics (<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='red'>-12.2%</font>) is down on below-average volume. Share were up over&nbsp;<font color='green'>10%</font>&nbsp;early in the session before retracing.</li><li>Earlier today, the company <a href=\"https://seekingalpha.com/pr/17209749-cytori-reports-sustained-benefit-cell-therapy-erectile-dysfunction-trial\" target=\"_blank\">announced </a>the publication of results from a Denmark-based study evaluating Cytori Cell Therapy in men with erectile dysfunction &#40;ED&#41; following radical prostatectomy (surgical removal of the prostate).</li><li>A single administration of the autologous adipose-derived regenerative cells produced a significant improvement in incontinence, but their effect on ED was mixed. At month 12 after surgery, median Erection Hardness Scores were unchanged in the combined group of 21 patients, but improved slightly in a subset of patients who were continent. Over half (53.3%) of continent patients (n=8/15) could function well enough for intercourse.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368729\" data-linked=\"Cytori gives up early gains, down 12%\" data-tweet=\"$CYTX $PSTV - Cytori gives up early gains, down 12% https://seekingalpha.com/news/3368729-cytori-gives-up-early-gains-down-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3368729-cytori-gives-up-early-gains-down-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368726\" data-ts=\"1531164508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEN\" target=\"_blank\">GEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368726-genesis-healthcare-down-14-after-sabra-transaction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesis Healthcare down 14% after Sabra transaction</a></h4><ul><li>Genesis Healthcare (<a href='https://seekingalpha.com/symbol/GEN' title='Genesis Healthcare, Inc.'>GEN</a> <font color='red'>-13.7%</font>) is down on more than triple normal volume. Earlier today, Sabra Health Care REIT (<a href='https://seekingalpha.com/symbol/SBRA' title='Sabra Health Care REIT, Inc.'>SBRA</a> <font color='red'>-1.8%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17210259-sabra-health-care-reit-inc-completes-sale-nine-facilities-leased-genesis-sells-facility\" target=\"_blank\">announced </a>the completion of the sale of nine facilities to Genesis for $81.4M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368726\" data-linked=\"Genesis Healthcare down 14% after Sabra transaction\" data-tweet=\"$GEN $GEN $SBRA - Genesis Healthcare down 14% after Sabra transaction https://seekingalpha.com/news/3368726-genesis-healthcare-down-14-after-sabra-transaction?source=tweet\" data-url=\"https://seekingalpha.com/news/3368726-genesis-healthcare-down-14-after-sabra-transaction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368722\" data-ts=\"1531163516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRT\" target=\"_blank\">ASRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368722-depomed-up-16-on-reported-patent-settlement-purdue-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Depomed up 16% on reported patent settlement with Purdue Pharma</a></h4><ul><li>Depomed (DEPO <font color='green'>+15.9%</font>) is up on triple normal volume in response to its reported patent settlement with Purdue Pharma. Details are scarce, however.</li><li><strong>Update</strong>: The company is currently negotiating with Purdue to settle the patent infringement dispute.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368722\" data-linked=\"Depomed up 16% on reported patent settlement with Purdue Pharma\" data-tweet=\"$ASRT - Depomed up 16% on reported patent settlement with Purdue Pharma https://seekingalpha.com/news/3368722-depomed-up-16-on-reported-patent-settlement-purdue-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3368722-depomed-up-16-on-reported-patent-settlement-purdue-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368719\" data-ts=\"1531162931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368719-semileds-high-on-movers-chart-39-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SemiLEDs high on movers chart with 39% gain</a></h4><ul>   <li>SemiLEDs (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) opened up $0.21 today but has moved through the afternoon to <font color='green'>rise 39%</font> and become one of the market's top movers today.</li>    <li>The move's coming on no catalyst in particular.</li>    <li>Volume's already quadruple normal, though -- and actually more than 10 times recent slow volume.</li>    <li>More than three-quarters of shares are held by insiders, according to Yahoo Finance, and the short percentage of float stands at 9.14%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368719\" data-linked=\"SemiLEDs high on movers chart with 39% gain\" data-tweet=\"$LEDS - SemiLEDs high on movers chart with 39% gain https://seekingalpha.com/news/3368719-semileds-high-on-movers-chart-39-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3368719-semileds-high-on-movers-chart-39-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368717\" data-ts=\"1531162557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368717-technology-top-5-gainers-losers-of-2_55-pm-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (07/09/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/AUO' title='AU Optronics Corp.'>AUO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+10%</font>.</li>      <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/EGAN' title='eGain Communications Corp.'>EGAN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PS' title='Pluralsight, Inc.'>PS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368717\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (07/09/2018)\" data-tweet=\"$LEDS $LEDS $NNDM - Technology - Top 5 Gainers / Losers as of 2.55 PM (07/09/2018) https://seekingalpha.com/news/3368717-technology-top-5-gainers-losers-of-2_55-pm-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368717-technology-top-5-gainers-losers-of-2_55-pm-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368715\" data-ts=\"1531162347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368715-transocean-upgraded-oasis-petroleum-downgraded-susquehanna\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean upgraded, Oasis Petroleum downgraded at Susquehanna</a></h4><ul>     <li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+4.6%</font>) enjoys strong gains after Susquehanna <a href=\"https://www.barrons.com/articles/energy-marathon-oil-and-transocean-look-like-buys-1531146197\" target=\"_blank\">upgrades</a> shares to Positive from Neutral with a $16 price target, while the firm downgrades Oasis Petroleum (<a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color='green'>+0.8%</font>) to Neutral from Positive with a $14 price target.</li>     <li>\"Offshore floater contracting activity has begun to rebound, and we believe more positive commentary across several of the companies suggests the industry is beginning to heal, and better utilization could be ahead in 2019 and 2020,\" Susquehanna says in raising its rating on RIG for more leverage to the sector.</li>     <li>The firm thinks OAS shares, however, are fully valued after rising 55% YTD while the SPDR&nbsp;S&amp;P&nbsp;Oil and Gas Exploration and Production ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>) is just 18% higher.</li>     <li>Investors who want exposure to companies with substantial non-Permian production should instead buy Marathon Oil (<a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='green'>+3.3%</font>), which the firm rates Positive with a $26 price target, improved from $24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368715\" data-linked=\"Transocean upgraded, Oasis Petroleum downgraded at Susquehanna\" data-tweet=\"$RIG $RIG $OAS - Transocean upgraded, Oasis Petroleum downgraded at Susquehanna https://seekingalpha.com/news/3368715-transocean-upgraded-oasis-petroleum-downgraded-susquehanna?source=tweet\" data-url=\"https://seekingalpha.com/news/3368715-transocean-upgraded-oasis-petroleum-downgraded-susquehanna\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368714\" data-ts=\"1531161727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368714-banks-climb-for-third-day-anticipating-strong-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Banks climb for third day anticipating strong earnings</a></h4><ul><li>Financial stocks gain for the third day ahead of Q2 earnings reports, which kick off later this week. The Financial Select Sector SPDR ETF<font color='green'> gains&nbsp; 2.3%</font>&nbsp;in midafternoon trading, while the S&amp;P Banks Select Industry Index also&nbsp;<font color='green'>climbs 2.3%</font>.</li><li>Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+3.6%</font>) logged the largest gain of the big U.S. banks, while New York Community Bancorp (<a href='https://seekingalpha.com/symbol/NYCB' title='New York Community Bancorp Inc.'>NYCB</a> <font color='green'>+3.5%</font>) rose the most among regional banks.</li><li>Friday will be a big day for bank earnings: Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+2.7%</font>), Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='green'>+1.9%</font>), JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='green'>+3.2%</font>), and PNC Financial(<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='green'>+2.3%</font>) all report quarterly earnings.</li><li>Other gainers for today: BofI Holdings (<a href='https://seekingalpha.com/symbol/BOFI' title='BofI Holding, Inc.'>BOFI</a> <font color='green'>+2.9%</font>), SunTrust Banks (<a href='https://seekingalpha.com/symbol/STI' title='SunTrust Banks, Inc.'>STI</a> <font color='green'>+3.4%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='green'>+3.1%</font>),&nbsp; Bank of the Ozarks (OZRK <font color='green'>+2.9%</font>), and BB&amp;T (<a href='https://seekingalpha.com/symbol/BBT' title='BB&T Corporation'>BBT</a> <font color='green'>+2.8%</font>).</li><li>For the past month, the S&amp;P Banks Select Industry Index is down 2.6%, but it's up 3.4% year-to-date.</li><li>The optimism for financial stocks appears to be global. Royal Bank of Canada (<a href='https://seekingalpha.com/symbol/RY' title='Royal Bank of Canada'>RY</a> <font color='green'>+0.8%</font>), Bank of Montreal (<a href='https://seekingalpha.com/symbol/BMO' title='Bank of Montreal'>BMO</a> <font color='green'>+0.7%</font>), and Canadian Imperial Bank of Commerce (<a href='https://seekingalpha.com/symbol/CM' title='Canadian Imperial Bank of Commerce'>CM</a> <font color='green'>+0.7%</font>) rose. The only major Canadian bank to decline is Toronto-Dominion Bank (<a href='https://seekingalpha.com/symbol/TD' title='Toronto-Dominion Bank'>TD</a> <font color='red'>-0.2%</font>).</li><li>HSBC Holdings (<a href='https://seekingalpha.com/symbol/HSBC' title='HSBC Holdings PLC'>HSBC</a> <font color='green'>+1.6%</font>), Credit Suisse (<a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a> <font color='green'>+2.2%</font>), and Barclays (<a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a> <font color='green'>+1.2%</font>) lead overseas-based banks higher.</li><li>Investors also seem optimistic about credit card companies as American Express (<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a> <font color='green'>+1.5%</font>), Synchrony Financial (<a href='https://seekingalpha.com/symbol/SYF' title='Synchrony Financial'>SYF</a> <font color='green'>+3.3%</font>), Capital One (<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a> <font color='green'>+4.1%</font>), Discover Financial (<a href='https://seekingalpha.com/symbol/DFS' title='Discover Financial Services'>DFS</a> <font color='green'>+2%</font>), and Alliance Data Systems (<a href='https://seekingalpha.com/symbol/ADS' title='Alliance Data Systems Corporation'>ADS</a> <font color='green'>+1.4%</font>) all gaining more than 1%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368535-futures-build-last-weeks-gains\" target=\"_blank\">Futures build on last week's gains</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368714\" data-linked=\"Banks climb for third day anticipating strong earnings\" data-tweet=\"$BAC $BAC $NYCB - Banks climb for third day anticipating strong earnings https://seekingalpha.com/news/3368714-banks-climb-for-third-day-anticipating-strong-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3368714-banks-climb-for-third-day-anticipating-strong-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368713\" data-ts=\"1531161298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWK\" target=\"_blank\">SWK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368713-stanley-black-decker-to-pay-100m-in-rhode-island-site-cleanup-doj-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stanley Black &amp; Decker to pay $100M in Rhode Island site cleanup, DoJ says</a></h4><ul>     <li>Stanley Black &amp; Decker (<a href='https://seekingalpha.com/symbol/SWK' title='Stanley Black & Decker, Inc.'>SWK</a> <font color='green'>+1.8%</font>) <a href=\"https://www.justice.gov/opa/pr/100-million-settlement-will-speed-cleanup-work-centredale-manor-superfund-site-north\" target=\"_blank\">agrees to pay $100M</a> to help clean up dioxin contaminated sediment and soil at the Centredale Manor Restoration Project Superfund Site in Rhode Island, the U.S. Department of Justice announces.</li>     <li>The cleanup remedy includes excavation of contaminated sediment and floodplain soil from the Woonasquatucket River, including from adjacent residential properties, the DoJ says.</li>     <li>SWK says it is <a href=\"https://www.sec.gov/Archives/edgar/data/93556/000009355618000023/centredale8-kdocument.htm\" target=\"_blank\">adding $78M to its reserve</a> for the site to $146M, which will be reflected in its Q2 2018 financial results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368713\" data-linked=\"Stanley Black &amp; Decker to pay $100M in Rhode Island site cleanup, DoJ says\" data-tweet=\"$SWK - Stanley Black &amp; Decker to pay $100M in Rhode Island site cleanup, DoJ says https://seekingalpha.com/news/3368713-stanley-black-decker-to-pay-100m-in-rhode-island-site-cleanup-doj-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3368713-stanley-black-decker-to-pay-100m-in-rhode-island-site-cleanup-doj-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368707\" data-ts=\"1531159268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAT\" target=\"_blank\">TAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368707-energy-materials-top-gainers-losers-of-2-00-pm-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (07/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368707\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (07/09/2018)\" data-tweet=\"$TAT $TAT $MCF - Energy/Materials - Top Gainers / Losers as of 2:00 PM (07/09/2018) https://seekingalpha.com/news/3368707-energy-materials-top-gainers-losers-of-2-00-pm-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368707-energy-materials-top-gainers-losers-of-2-00-pm-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368702\" data-ts=\"1531158147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368702-snap-gains-on-report-of-amazon-search-tie-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap gains on report of Amazon search tie-in</a></h4><ul><li>Some <a href=\"https://techcrunch.com/2018/07/09/snapchat-camera-search/\" target=\"_blank\">digging</a> by an app researcher reveals hidden code inside of SnapChat that delivers search users to Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.1%</font>) listings.</li><li>Visual product search could make Snapchat&rsquo;s camera tool a differentiator from Instagram, says TechCrunch Editor-At-Large Josh Constine.</li><li>Shares of Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) are&nbsp;<font color='green'>up 2.68%</font>&nbsp;on the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368702\" data-linked=\"Snap gains on report of Amazon search tie-in\" data-tweet=\"$AMZN $AMZN $SNAP - Snap gains on report of Amazon search tie-in https://seekingalpha.com/news/3368702-snap-gains-on-report-of-amazon-search-tie-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3368702-snap-gains-on-report-of-amazon-search-tie-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368701\" data-ts=\"1531158026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368701-biotechs-give-up-gains-after-trump-tweet-on-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs give up gains after Trump tweet on prices</a></h4><ul><li>The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='red'>-0.7%</font>) slips 1.5% from its intraday high of $101.17 after President Trump <a href=\"https://twitter.com/realDonaldTrump?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\" target=\"_blank\">tweeted </a>(again)&nbsp;his displeasure over recent price hikes by drug makers, including Pfizer.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/PPH' title='VanEck Vectors Pharmaceutical ETF'>PPH</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='green'>+1.4%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='green'>+2.4%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+1.1%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='green'>+0.8%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+0.1%</font>)(VRX <font color='green'>+2.6%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-0.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368701\" data-linked=\"Biotechs give up gains after Trump tweet on prices\" data-tweet=\"$RHHBY $XBI $XLV - Biotechs give up gains after Trump tweet on prices https://seekingalpha.com/news/3368701-biotechs-give-up-gains-after-trump-tweet-on-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3368701-biotechs-give-up-gains-after-trump-tweet-on-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>157&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368700\" data-ts=\"1531157558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368700-twitter-pares-losses-cfo-comments-on-user-metrics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter pares losses as CFO comments on user metrics</a></h4><ul>   <li>Responding to reports of a <a href=\"https://seekingalpha.com/news/3368452-post-twitter-suspension-pace-hit-user-growth\" target=\"_blank\">massive account sweep</a> (and a <a href=\"https://seekingalpha.com/news/3368636-twitter-minus-8_4-percent-report-mass-suspensions\" target=\"_blank\">precipitous stock fall</a> today), Twitter Chief Financial Officer Ned Segal offers <a href=\"https://twitter.com/nedsegal/status/1016371745933033472\" target=\"_blank\">clarifications via his account</a>.</li>    <li>\"Some clarifications: most accounts we remove are not included in our reported metrics as they have not been active on the platform for 30 days or more, or we catch them at sign up and they are never counted,\" Segal says.</li>    <li>A <i>Washington Post</i> story on some 70M suspensions of fake accounts noted worries that the company might show a rare monthly user decline when it reports earnings later this month.</li>    <li>\"If we removed 70M accounts from our reported metrics, you would hear directly from us,\" he goes on. \"This article reflects us getting better at improving the health of the service. Look forward to talking more on our earnings call July 27!\"</li>    <li>Shares in <a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a> are rebounding somewhat, now <font color='red'>down 4.5%</font>; they were <font color='red'>down as much as 9.8%</font> at their session low today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368700\" data-linked=\"Twitter pares losses as CFO comments on user metrics\" data-tweet=\"$TWTR - Twitter pares losses as CFO comments on user metrics https://seekingalpha.com/news/3368700-twitter-pares-losses-cfo-comments-on-user-metrics?source=tweet\" data-url=\"https://seekingalpha.com/news/3368700-twitter-pares-losses-cfo-comments-on-user-metrics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368699\" data-ts=\"1531157194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOTS\" target=\"_blank\">IOTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368699-adesto-technologies-reports-preliminary-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adesto Technologies reports preliminary Q2 results</a></h4><ul>     <li>Adesto Technologies (<a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='red'>-21.8%</font>) <a href=\"https://seekingalpha.com/pr/17209863-adesto-technologies-corporation-announces-preliminary-second-quarter-2018-financial-results\" target=\"_blank\">now expects</a> revenue for the Q2 to be ~$18.1M to $18.3M vs. a consensus of $18.55M and prior expectations of $18.1M to $19.0M.</li>     <li>The company expects gross margin to be 42% to 44%, below the company&rsquo;s prior expectations of 46% to 48%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368499-adesto-technologies-announces-proposed-public-offering-common-stock\" target=\"_blank\">Adesto Technologies announces proposed public offering of common stock</a> (July 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368699\" data-linked=\"Adesto Technologies reports preliminary Q2 results\" data-tweet=\"$IOTS - Adesto Technologies reports preliminary Q2 results https://seekingalpha.com/news/3368699-adesto-technologies-reports-preliminary-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3368699-adesto-technologies-reports-preliminary-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368780\" data-ts=\"1531156227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNI\" target=\"_blank\">CNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368780-canadian-national-rail-upgraded-to-buy-from-hold-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian National Rail upgraded to Buy from Hold at Deutsche Bank</a></h4><ul>     <li>Canadian National Railway (<a href='https://seekingalpha.com/symbol/CNI' title='Canadian National Railway Company'>CNI</a> <font color='green'>+2.7%</font>) is higher after Deutsche Bank <a href=\"https://thefly.com/thestreet/realmoney/index.php/CNIid2755131/CNI-Deutsche-Bank-upgrades-Canadian-National-to-Buy-with--price-target\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $95 price target, raised from $81, saying the company's period of incremental capital investment has \"sown the seeds of recovery.\" with CNI now better prepared to capitalize on abundant top-line opportunities.</li>     <li>Following an uncharacteristically challenging period for CNI, the firm believes the company is now in a better position to benefit from the top-line growth opportunities it has been highlighting since its investor day last June.</li><li>Deutsche Bank also believes strong pricing and operating leverage will drive significant margin expansion and earnings growth, with its 2020 EPS forecast now 10% above consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368780\" data-linked=\"Canadian National Rail upgraded to Buy from Hold at Deutsche Bank\" data-tweet=\"$CNI - Canadian National Rail upgraded to Buy from Hold at Deutsche Bank https://seekingalpha.com/news/3368780-canadian-national-rail-upgraded-to-buy-from-hold-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3368780-canadian-national-rail-upgraded-to-buy-from-hold-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368695\" data-ts=\"1531155772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YAHOY\" target=\"_blank\">YAHOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368695-yahoo-japan-mulls-buyback-to-ease-altaba-stake-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yahoo Japan mulls buyback to ease Altaba stake sale</a></h4><ul>   <li>Yahoo Japan (<a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a>) confirms a report that it's considering a share buyback but that decision hasn't been made.</li>    <li>Nikkei reported that the company may buy back &yen;200B worth in a scheme to allow Altaba (NASDAQ:<a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a>) to sell part of its stake in Yahoo Japan.</li>    <li>ADRs are on the move today on Nasdaq: <a href='https://seekingalpha.com/symbol/YAHOY' title='Yahoo Japan Corp. ADR'>OTCPK:YAHOY</a> <font color='green'>+6.6%</font>. Related: <a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a> <font color='green'>+2.6%</font>; <a href='https://seekingalpha.com/symbol/AABA' title='Altaba, Inc.'>AABA</a> <font color='red'>-0.5%</font>.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368695\" data-linked=\"Yahoo Japan mulls buyback to ease Altaba stake sale\" data-tweet=\"$YAHOY $YAHOY $AABA - Yahoo Japan mulls buyback to ease Altaba stake sale https://seekingalpha.com/news/3368695-yahoo-japan-mulls-buyback-to-ease-altaba-stake-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3368695-yahoo-japan-mulls-buyback-to-ease-altaba-stake-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368693\" data-ts=\"1531155667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LC\" target=\"_blank\">LC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368693-financials-top-gainers-losers-of-1-00-pm-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (07/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LC' title='LendingClub Corporation'>LC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/IHT' title='Innsuites Hospitality Trust'>IHT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology'>AIHS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368693\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (07/09/2018)\" data-tweet=\"$LC $LC $FANH - Financials - Top Gainers / Losers as of 1:00 PM (07/09/2018) https://seekingalpha.com/news/3368693-financials-top-gainers-losers-of-1-00-pm-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368693-financials-top-gainers-losers-of-1-00-pm-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368687\" data-ts=\"1531154595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDS\" target=\"_blank\">PDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368687-precision-drillingplus-7-after-winning-kuwait-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precision Drilling +7% after winning Kuwait contract</a></h4><ul>     <li>Precision Drilling (<a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+6.8%</font>) surges after <a href=\"https://seekingalpha.com/pr/17209832-precision-drilling-corporation-announces-kuwait-contract-award-activity-update\" target=\"_blank\">winning a five-year contract award</a> to build a ST-3000 drilling rig in Kuwait with an optional one year extension; financial terms are not disclosed.</li>     <li>PDS has five active rigs in Kuwait on long term contract and expects the sixth rig to begin operations in Q3 2019.</li>     <li>Also, PDS says it has 54 active rigs in Canada with visibility to exceed 60 active rigs by mid-August, surpassing peak rig count in Q3 a year ago, while demand in the U.S. strengthens with 78 rigs  currently active and visibility to reach 80 rigs by the end of July.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368687\" data-linked=\"Precision Drilling +7% after winning Kuwait contract\" data-tweet=\"$PDS - Precision Drilling +7% after winning Kuwait contract https://seekingalpha.com/news/3368687-precision-drillingplus-7-after-winning-kuwait-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3368687-precision-drillingplus-7-after-winning-kuwait-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368686\" data-ts=\"1531154563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAF\" target=\"_blank\">STAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368686-midday-gainers-losers-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (07/09/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+255%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='green'>+56%</font>. <a href='https://seekingalpha.com/symbol/EVK' title='Ever-Glory International Group, Inc'>EVK</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a> <font color='green'>+12%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/IOTS' title='Adesto Technologies'>IOTS</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368686\" data-linked=\"Midday Gainers / Losers (07/09/2018)\" data-tweet=\"$STAF $STAF $BNTC - Midday Gainers / Losers (07/09/2018) https://seekingalpha.com/news/3368686-midday-gainers-losers-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368686-midday-gainers-losers-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368685\" data-ts=\"1531154437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368685-jd-l-catterton-partner-secoo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD, L Catterton partner with Secoo</a></h4><ul>   <li>JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color='green'>+0.2%</font>) and private-equity based firm L Catterton Asia have set a <a href=\"https://seekingalpha.com/pr/17210247-l-catterton-asia-jd-com-announce-strategic-partnership-secoo\" target=\"_blank\">strategic partnership</a> with luxury retailer Secoo Holding Limited (<a href=\"http://seekingalpha.com/symbol/SECO\" target=\"_blank\">SECO</a> <font color='green'>+6.4%</font>).</li>    <li>That will include a $175M investment from JD and L Catterton's Asian division.</li>    <li>Secoo will leverage L Catterton's global fashion and retail expertise to pursue further expansion in the luxury market.</li>    <li>As for JD: \"This partnership will help us enhance our luxury capabilities and provide the best possible luxury shopping experience to consumers in China,\" says the company's Shengli Hu. \"Chinese consumers are increasingly discerning about their luxury purchases, demanding more variety and choice than ever.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368685\" data-linked=\"JD, L Catterton partner with Secoo\" data-tweet=\"$JD $JD $SECO - JD, L Catterton partner with Secoo https://seekingalpha.com/news/3368685-jd-l-catterton-partner-secoo?source=tweet\" data-url=\"https://seekingalpha.com/news/3368685-jd-l-catterton-partner-secoo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368665\" data-ts=\"1531152045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVK\" target=\"_blank\">EVK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368665-consumer-top-5-gainers-losers-of-12-00-pm-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EVK' title='Ever-Glory International Group, Inc'>EVK</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/JRSH' title='Jerash Holdings &#40;US&#41; Inc'>JRSH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/RIBT' title='RiceBran Technologies'>RIBT</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/JVA' title='Coffee Holding Co., Inc'>JVA</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368665\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/09/2018)\" data-tweet=\"$EVK $EVK $HELE - Consumer - Top 5 Gainers / Losers as of 12:00 PM (07/09/2018) https://seekingalpha.com/news/3368665-consumer-top-5-gainers-losers-of-12-00-pm-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368665-consumer-top-5-gainers-losers-of-12-00-pm-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368662\" data-ts=\"1531151455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368662-nintendoplus-3-after-clsa-raises-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nintendo +3% after CLSA raises to Buy</a></h4><ul>    <li>Nintendo (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>) is <font color='green'>up 3%</font> in U.S. trading after a boost to Buy from CLSA, up from Outperform.</li>    <li>The firm updated its price target down to &yen;44,000 from &yen;54,000; that's a below-average price target that still implies 24% upside from current price.</li>    <li>Shares <font color='green'>rose 2.5%</font> in Tokyo today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368662\" data-linked=\"Nintendo +3% after CLSA raises to Buy\" data-tweet=\"$NTDOY - Nintendo +3% after CLSA raises to Buy https://seekingalpha.com/news/3368662-nintendoplus-3-after-clsa-raises-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3368662-nintendoplus-3-after-clsa-raises-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368661\" data-ts=\"1531151117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHLR\" target=\"_blank\">WHLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368661-wheeler-reit-gains-shareholder-seeks-to-replace-least-three-directors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheeler REIT gains as shareholder seeks to replace at least three directors</a></h4><ul><li>Wheeler REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a>)<font color='green'> gains as much as 2.6%</font>&nbsp;after shareholder Stilwell Group issues a second letter to fellow shareholders, saying it wants to replace at least three legacy directors on the REIT's board.</li><li>Joseph Stilwell says a January issue of 1.4M shares of convertible preferred stock sold at an $8.50 discount to face value destroyed more than $12M in value for common stockholders--\"&nbsp;something I've never seen occur at even a reasonably healthy company in my 35 years of working on&nbsp;Wall Street,\" Stilwell writes.</li><li>Stilwell Activist Investments beneficially owns about 671,610 shares of common stock.</li><li>WHLR has declined 44% since its closing stock price of $7.81 (adjusted for dividends) on Dec. 29, the last trading day of 2017.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17210511-stilwell-group-sends-second-letter-shareholders-wheeler-real-estate-investment-trust\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3367137-wheeler-reit-refinancing-moves-cut-debt-20m\" target=\"_blank\">Wheeler REIT refinancing moves cut debt by more than $20M</a> (June 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368661\" data-linked=\"Wheeler REIT gains as shareholder seeks to replace at least three directors\" data-tweet=\"$WHLR - Wheeler REIT gains as shareholder seeks to replace at least three directors https://seekingalpha.com/news/3368661-wheeler-reit-gains-shareholder-seeks-to-replace-least-three-directors?source=tweet\" data-url=\"https://seekingalpha.com/news/3368661-wheeler-reit-gains-shareholder-seeks-to-replace-least-three-directors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368653\" data-ts=\"1531150352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRKGF\" target=\"_blank\">GRKGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368653-world-cup-fever-filters-down-to-bottom-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">World Cup fever filters down to some bottom lines</a></h4><ul> <li>Greene King (<a href='https://seekingalpha.com/symbol/GRKGF' title='Greene King Plc.'>OTC:GRKGF</a>, <a href='https://seekingalpha.com/symbol/GKNGY' title='Greene King Plc. ADR'>OTCPK:GKNGY</a>) and Marston's (<a href='https://seekingalpha.com/symbol/MARZF' title='Marston&#39;s plc.'>OTCPK:MARZF</a>, <a href='https://seekingalpha.com/symbol/MRTPY' title='Marston&#39;s plc. ADR'>OTC:MRTPY</a>) are both <font color='green'>up about 2.30%</font> in London trading after England advanced to the semi-finals of the World Cup.</li> <li>The extra games for the Three Lions essentially works out to the equivalent of a few days worth of extra revenue for the pub operators.</li> <li>The strong performance by European teams could also boost results for Coca-Cola European Partners (NYSE:<a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a>) and Coca Cola HBC (<a href='https://seekingalpha.com/symbol/CCHBF' title='COCA COLA HBC LTD'>OTC:CCHBF</a>, <a href='https://seekingalpha.com/symbol/CCHGY' title='COCA COLA HBC UNSP/ADR'>OTCPK:CCHGY</a>), according to analysts.</li> <li>Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+0.5%</font>) has France, England and Croatia still alive in the tournament as far as uniform sponsorships, while Adidas (<a href='https://seekingalpha.com/symbol/ADDYY' title='adidas AG ADR'>OTCQX:ADDYY</a>) is down to Belgium. Reports indicate that England merchandise has been the hottest seller of the four teams still remaining.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368653\" data-linked=\"World Cup fever filters down to some bottom lines\" data-tweet=\"$GRKGF $GRKGF $GKNGY - World Cup fever filters down to some bottom lines https://seekingalpha.com/news/3368653-world-cup-fever-filters-down-to-bottom-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3368653-world-cup-fever-filters-down-to-bottom-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368652\" data-ts=\"1531149744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGSGY\" target=\"_blank\">TGSGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368652-tgs-nopec-geophysical-updates-on-q2-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TGS Nopec Geophysical updates on Q2 revenue</a></h4><ul>     <li>TGS&nbsp;Nopec Geophysical (<a href='https://seekingalpha.com/symbol/TGSGY' title='TGS Nopec Geophysical Company ADR'>OTCPK:TGSGY</a> <font color='green'>+6%</font>) <a href=\"http://www.tgs.com/News/2018/Q2_2018_Revenue_Update/\" target=\"_blank\">expects</a> net revenues for the Q218 to be ~$158M (+47% Y/Y).</li>     <li>Kristian Johansen, CEO, TGS:&nbsp;&nbsp;\"Our strong Q2 revenue performance, driven by late sales from our data library, is further evidence of improvement in the global market for seismic data.  Customer activity is significantly higher than one year ago, although E&amp;P companies are still being selective and disciplined with respect to new data purchases.  As such, the market is expected to remain volatile in the near-term\".</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368652\" data-linked=\"TGS Nopec Geophysical updates on Q2 revenue\" data-tweet=\"$TGSGY $TGSNF - TGS Nopec Geophysical updates on Q2 revenue https://seekingalpha.com/news/3368652-tgs-nopec-geophysical-updates-on-q2-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3368652-tgs-nopec-geophysical-updates-on-q2-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368637\" data-ts=\"1531148435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNTC\" target=\"_blank\">BNTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368637-healthcare-top-5-gainers-losers-of-11-00-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/KZIA' title='Kazia Therapeutics Ltd'>KZIA</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LENS' title='Presbia'>LENS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368637\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/09/2018)\" data-tweet=\"$BNTC $BNTC $KZIA - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/09/2018) https://seekingalpha.com/news/3368637-healthcare-top-5-gainers-losers-of-11-00-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368637-healthcare-top-5-gainers-losers-of-11-00-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368636\" data-ts=\"1531148239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368636-twitterminus-8_4-after-report-of-mass-suspensions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter -8.4% after report of mass suspensions</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) has led S&amp;P downdrafters today, now <font color='red'>-8.4%</font>, in its first market action since a <a href=\"https://seekingalpha.com/news/3368452-post-twitter-suspension-pace-hit-user-growth\" target=\"_blank\">late-Friday report</a> that the company is suspending more than a million accounts a day for fakery or spam involvement.</li>    <li>That number's high enough to lead to a drop in monthly users when the company issues its Q2 report.</li>    <li>Monthly active users were up 3% in Q1, to 336M.</li>    <li>The company's set to report before the open on July 27.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368636\" data-linked=\"Twitter -8.4% after report of mass suspensions\" data-tweet=\"$TWTR - Twitter -8.4% after report of mass suspensions https://seekingalpha.com/news/3368636-twitterminus-8_4-after-report-of-mass-suspensions?source=tweet\" data-url=\"https://seekingalpha.com/news/3368636-twitterminus-8_4-after-report-of-mass-suspensions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368633\" data-ts=\"1531147796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLPH\" target=\"_blank\">DLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368633-forward-motion-again-for-auto-suppliers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forward motion again for auto suppliers</a></h4><ul> <li>Traders are showing some confidence in auto suppliers again as the latest trade/tariff developments are digested. An upgrade from Morgan Stanley on Delphi Technologies to Overweight from Equal-Weight is also helping to swing sentiment around to the positive side.</li> <li>Notable gainers include Delphi Technologies (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='green'>+5.7%</font>), Dana (<a href='https://seekingalpha.com/symbol/DAN' title='Dana, Inc.'>DAN</a> <font color='green'>+3.5%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+3.2%</font>), Meritor (<a href='https://seekingalpha.com/symbol/MTOR' title='Meritor, Inc.'>MTOR</a> <font color='green'>+3.7%</font>), BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color='green'>+2.5%</font>) and Allison Transmission Holdings (<a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a> <font color='green'>+2.1%</font>). Overall, 29 out of the 37 publicly-traded auto supplier stocks with a market cap of over $50M are showing some sort of gain on the day.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3368633\" data-linked=\"Forward motion again for auto suppliers\" data-tweet=\"$DLPH $DLPH $DAN - Forward motion again for auto suppliers https://seekingalpha.com/news/3368633-forward-motion-again-for-auto-suppliers?source=tweet\" data-url=\"https://seekingalpha.com/news/3368633-forward-motion-again-for-auto-suppliers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368626\" data-ts=\"1531147339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368626-acadia-down-5-on-bearish-sirf-article\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia down 5% on bearish SIRF article</a></h4><ul><li>ACADIA Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-4.7%</font>) slips on average volume on the heels of a bearish online <a href=\"http://sirf-online.org/2018/07/09/acadia-pharmaceuticals-this-is-not-a-pharmaceuticals-company/\" target=\"_blank\">article</a> by the Southern Investigative Reporting Foundation &#40;SIRF&#41;.</li><li>The article cites the previously reported level of adverse events related to Parkinson's disease psychosis med Nuplazid (pimavanserin).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3348684-acadia-20-percent-fda-relook-nuplazid-safety-data\" target=\"_blank\">Acadia down 20% on FDA relook at Nuplazid safety data</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344387-acadia-pharma-17-percent-premarket-nuplazid-safety-concerns\" target=\"_blank\">Acadia Pharma down 17% premarket on Nuplazid safety concerns</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368626\" data-linked=\"Acadia down 5% on bearish SIRF article\" data-tweet=\"$ACAD - Acadia down 5% on bearish SIRF article https://seekingalpha.com/news/3368626-acadia-down-5-on-bearish-sirf-article?source=tweet\" data-url=\"https://seekingalpha.com/news/3368626-acadia-down-5-on-bearish-sirf-article\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368627\" data-ts=\"1531147106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAY\" target=\"_blank\">PLAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368627-dinosaur-rally-for-dave-busters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dinosaur rally for Dave &amp; Buster&#39;s</a></h4><ul> <li>Dave &amp; Buster's Entertainment (<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a> <font color='green'>+4.4%</font>) is likely to see a huge bounce in traffic due to its virtual reality dinosaurs arcade game based off of Jurassic World, according to SunTrust.</li> <li>The latest Jurassic installment has brought in $333M in U.S. theaters and over $1.06B globally in a strong run that's still going on.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3368627\" data-linked=\"Dinosaur rally for Dave &amp; Buster&#39;s\" data-tweet=\"$PLAY - Dinosaur rally for Dave &amp; Buster&#39;s https://seekingalpha.com/news/3368627-dinosaur-rally-for-dave-busters?source=tweet\" data-url=\"https://seekingalpha.com/news/3368627-dinosaur-rally-for-dave-busters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368623\" data-ts=\"1531146644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368623-musk-to-visit-china-this-week-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Musk to visit China this week - Bloomberg</a></h4><ul><li>Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+0.2%</font>) CEO Elon Musk plans to <a href=\"https://www.bloomberg.com/news/articles/2018-07-09/tesla-s-musk-is-said-to-visit-shanghai-for-event-with-government\" target=\"_blank\">visit</a> Shanghai tomorrow and Beijing from Wednesday through Thursday, sources tell Bloomberg.</li><li>The details on the purpose of the trip aren't known yet, although Musk mentioned last month the company's goal to build a car, battery-pack and powertrain plant in Shanghai.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368599-tesla-drifts-higher-report-musk-visit-shanghai\" target=\"_blank\">Tesla drifts higher on report of Musk visit to Shanghai</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368623\" data-linked=\"Musk to visit China this week - Bloomberg\" data-tweet=\"$TSLA - Musk to visit China this week - Bloomberg https://seekingalpha.com/news/3368623-musk-to-visit-china-this-week-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3368623-musk-to-visit-china-this-week-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368613\" data-ts=\"1531146521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUSF\" target=\"_blank\">BLUSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368613-bellus-health-launches-early-stage-of-lead-drug-bluminus-5937-for-chronic-cough-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BELLUS Health launches early-stage of lead drug BLU-5937 for chronic cough; shares up 4%</a></h4><ul><li>Thinly traded nano cap BELLUS Health (<a href='https://seekingalpha.com/symbol/BLUSF' title='BELLUS Health Inc.'>OTCPK:BLUSF</a> <font color='green'>+3.8%</font>) <a href=\"https://seekingalpha.com/pr/17209973-bellus-health-initiates-phase-1-clinical-study-chronic-cough-drug-candidate-bluminus-5937\" target=\"_blank\">initiates </a>a Phase 1 clinical trial assessing the safety, tolerability and pharmacokinetics of lead candidate BLU-5937, in development for the treatment of chronic cough.&nbsp;Results should be available in Q4.</li><li>A Phase 2 proof-of-concept study should launch in 2019.</li><li>Small molecule <a href=\"http://www.bellushealth.com/English/pipeline/BLU-5937-for-Chronic-Cough/default.aspx\" target=\"_blank\">BLU-5937</a> is a orally available antagonist of the P2X3 receptor, a validated target for chronic cough. The company says preclinical tests showed that BLU-5937 significantly reduced cough with no taste loss, an unwanted side effect associated with Merck's (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-0.1%</font>) P2X3 antagonist gefapixant (MK-7264).</li></ul><div class=\"tiny-share-widget\" data-id=\"3368613\" data-linked=\"BELLUS Health launches early-stage of lead drug BLU-5937 for chronic cough; shares up 4%\" data-tweet=\"$BLUSF $BLUSF $MRK - BELLUS Health launches early-stage of lead drug BLU-5937 for chronic cough; shares up 4% https://seekingalpha.com/news/3368613-bellus-health-launches-early-stage-of-lead-drug-bluminus-5937-for-chronic-cough-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3368613-bellus-health-launches-early-stage-of-lead-drug-bluminus-5937-for-chronic-cough-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368620\" data-ts=\"1531146272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368620-cs-upgrades-baidu-companys-ai-guru-to-exit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CS upgrades Baidu; company&#39;s AI guru to exit</a></h4><ul>   <li>Credit Suisse sees nearly 20% upside in Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='green'>+2.9%</font>), upgrading ADRs to Outperform.</li>    <li>Analyst Thomas Chong set a price target of $307, 22% up from Friday's close and 18% higher than current pricing.</li>    <li>Meanwhile, a key artificial-intelligence exec in the company is exiting. Cheng (Jesse) Lyu, founder of Baidu unit Raven Tech and previously the company's GM of intelligent hardware, is leaving the company for personal reasons.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368603-baidu-upgraded-keybanc-shares-nearly-4-percent\" target=\"_blank\">Baidu upgraded at KeyBanc; shares up nearly 4%</a> (Jul. 09 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368620\" data-linked=\"CS upgrades Baidu; company&#39;s AI guru to exit\" data-tweet=\"$BIDU - CS upgrades Baidu; company&#39;s AI guru to exit https://seekingalpha.com/news/3368620-cs-upgrades-baidu-companys-ai-guru-to-exit?source=tweet\" data-url=\"https://seekingalpha.com/news/3368620-cs-upgrades-baidu-companys-ai-guru-to-exit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368598\" data-ts=\"1531145850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIHO\" target=\"_blank\">HIHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368598-highway-holdings-up-3-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Highway Holdings up 3% post Q4 results</a></h4><ul><li>Highway Holdings (<a href='https://seekingalpha.com/symbol/HIHO' title='Highway Holdings Limited'>HIHO</a> <font color='green'>+3.6%</font>) reported Q4 revenue of $4.11M (-11.4% Y/Y) and net income of $0.20 per diluted share compared to $0.06 a year ago.</li><li>Q4 Overall margins: Gross&nbsp;<font color='green'>improved by 1,711 bps</font>&nbsp;to 51.8% and operating&nbsp;<font color='green'>improved by 1,408 bps</font>&nbsp;to 21.3%. Improvement in operational margins was due to acceptance of price increases from certain customers and the strategic elimination of low-margin business.</li><li>SG&amp;A expenses were $1.27M a decrease of 1.8% Y/Y.</li><li>Total cash was $11.3M as of March 31, 2018.</li><li>Company's expansion in Myanmar has become more attractive to existing and prospective customers due to the economic impact of escalating operational costs in China.</li><li>&ldquo;The manufacturing cost advantage of utilizing further automation and the benefits of Myanmar&rsquo;s favorable labor costs are mostly passed through to our customers, which contributes to lower pricing and sales turnover. As a result, we anticipate some sales softness as we commence a new fiscal year, but remain cautiously optimistic about our longer-term prospects,&rdquo; mentioned Roland Kohl, Chairman, president and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368528-highway-holdings-reports-q4-results\" target=\"_blank\">Highway Holdings reports Q4 results</a> (July 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368598\" data-linked=\"Highway Holdings up 3% post Q4 results\" data-tweet=\"$HIHO - Highway Holdings up 3% post Q4 results https://seekingalpha.com/news/3368598-highway-holdings-up-3-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3368598-highway-holdings-up-3-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368614\" data-ts=\"1531145568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368614-aristaplus-2_4-piper-jaffray-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista +2.4% with Piper Jaffray bullish</a></h4><ul>   <li>Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) has <font color='green'>moved up 2.4%</font> after an upgrade to Overweight from Piper Jaffray.</li>    <li>\"We are moving ANET to our No. 2 pick in networking for now, and expect to see a positive Q2 earnings report on Aug. 2,\" writes analyst Andrew Nowinski, pointing to a channel survey pointing to continued benefits from data-center switching losses, along with the company's campus product announcement in May and a lowering in overall sentiment. (h/t Bloomberg)</li>    <li>He's raised his price target to $315 from $268, implying 17% further upside from today's $268.59.</li>    <li>Analysts expect non-GAAP EPS of $1.70 from the company in its Q2 report, on revenues of $510.2M and EBITDA of $177.2M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368614\" data-linked=\"Arista +2.4% with Piper Jaffray bullish\" data-tweet=\"$ANET - Arista +2.4% with Piper Jaffray bullish https://seekingalpha.com/news/3368614-aristaplus-2_4-piper-jaffray-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3368614-aristaplus-2_4-piper-jaffray-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368607\" data-ts=\"1531145109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXL\" target=\"_blank\">AVXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368607-anavex-on-go-mid-stage-study-in-spain-for-anavex-2minus-73-in-parkinsons-dementia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anavex on go with mid-stage study in Spain for Anavex 2-73 in Parkinson&#39;s dementia</a></h4><ul><li>Anavex Life Sciences (<a href='https://seekingalpha.com/symbol/AVXL' title='Anavex Life Sciences Corp.'>AVXL</a> <font color='red'>-2.3%</font>) <a href=\"https://seekingalpha.com/pr/17209939-anavex-life-sciences-receives-approval-initiate-phase-2-clinical-trial-anavex-2minus-73\" target=\"_blank\">announces </a>that Spanish Agency for Medicinal Products and Medical Devices has signed off on a 14-week Phase 2 clinical trial evaluating ANAVEX 2-73 for the treatment of Parkinson's disease dementia &#40;PDD&#41;. Dosing should commence in the coming months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368607\" data-linked=\"Anavex on go with mid-stage study in Spain for Anavex 2-73 in Parkinson&#39;s dementia\" data-tweet=\"$AVXL - Anavex on go with mid-stage study in Spain for Anavex 2-73 in Parkinson&#39;s dementia https://seekingalpha.com/news/3368607-anavex-on-go-mid-stage-study-in-spain-for-anavex-2minus-73-in-parkinsons-dementia?source=tweet\" data-url=\"https://seekingalpha.com/news/3368607-anavex-on-go-mid-stage-study-in-spain-for-anavex-2minus-73-in-parkinsons-dementia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368603\" data-ts=\"1531144759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368603-baidu-upgraded-keybanc-shares-up-nearly-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu upgraded at KeyBanc; shares up nearly 4%</a></h4><ul><li>Analyst Hans Chung sees a change in prospects on the outlook for Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='green'>+3.4%</font>), and he upgrades to Overweight from Neutral. His $305 price target suggests about 20% upside from Friday's close.</li><li>Noted: Sustainable ramp on news feed ad revenue with daily run rate likely to double by the end of 2018; OCPC model could drive higher ARPU with advertisers.</li><li>The AI business, he says, is a call option for long-term growth.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3368603\" data-linked=\"Baidu upgraded at KeyBanc; shares up nearly 4%\" data-tweet=\"$BIDU - Baidu upgraded at KeyBanc; shares up nearly 4% https://seekingalpha.com/news/3368603-baidu-upgraded-keybanc-shares-up-nearly-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3368603-baidu-upgraded-keybanc-shares-up-nearly-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368601\" data-ts=\"1531144605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368601-softbank-telecom-unit-files-preliminary-ipo-sharesplus-2_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank telecom unit files preliminary IPO; shares +2.6%</a></h4><ul>   <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='green'>+2.6%</font>) has moved forward with its telecom unit's <a href=\"https://www.softbank.jp/en/corp/group/sbm/news/press/2018/20180709_02/\" target=\"_blank\">preliminary application to list shares</a> in Tokyo.</li>    <li>The unit, SoftBank Corp., had earlier taken steps along with its parent to release loan and bond guarantees and restructure board memberships.</li>    <li>The plan is for SoftBank Corp. to \"continue to be a major consolidated subsidiary\" of SoftBank Group after the listing.</li>    <li>Timing is uncertain as SoftBank needs the Tokyo Stock Exchange's approval for the listing after a review by Japan Exchange Regulation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368601\" data-linked=\"SoftBank telecom unit files preliminary IPO; shares +2.6%\" data-tweet=\"$SFTBY $SFTBF - SoftBank telecom unit files preliminary IPO; shares +2.6% https://seekingalpha.com/news/3368601-softbank-telecom-unit-files-preliminary-ipo-sharesplus-2_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3368601-softbank-telecom-unit-files-preliminary-ipo-sharesplus-2_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368599\" data-ts=\"1531144412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368599-tesla-drifts-higher-on-report-of-musk-visit-to-shanghai\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla drifts higher on report of Musk visit to Shanghai</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) starts the week off with a&nbsp;<font color='green'>1.85% gain</font>&nbsp;as reports circulate that Elon Musk is planning to visit Shanghai for an event with the local government.</li> <li>The company registered a new company in Shanghai's Free-Trade Zone earlier this year, which is expected to be part of a local manufacturing push and/or Tesla Gigafactory.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3368471-tesla-hikes-prices-china-response-tariffs\" target=\"_blank\">Tesla hikes prices in China in response to tariffs</a> (July 8)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368599\" data-linked=\"Tesla drifts higher on report of Musk visit to Shanghai\" data-tweet=\"$TSLA - Tesla drifts higher on report of Musk visit to Shanghai https://seekingalpha.com/news/3368599-tesla-drifts-higher-on-report-of-musk-visit-to-shanghai?source=tweet\" data-url=\"https://seekingalpha.com/news/3368599-tesla-drifts-higher-on-report-of-musk-visit-to-shanghai\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368592\" data-ts=\"1531143965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMT\" target=\"_blank\">AMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368592-american-towerminus-2_5-raymond-james-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Tower -2.5% with Raymond James downgrade</a></h4><ul>   <li>American Tower (NYSE:<a href='https://seekingalpha.com/symbol/AMT' title='American Tower Corporation'>AMT</a>) is <font color='red'>off 2.5%</font> after a downgrade to Market Perform at Raymond James.</li>    <li>That's a rare departure to a Neutral stance from a pack of analysts that has nearly two dozen Buy ratings on the stock.</li>    <li>Shares have <font color='green'>risen 10.9%</font> over the past year, but are <font color='green'>up just 2.2%</font> year-to-date.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368592\" data-linked=\"American Tower -2.5% with Raymond James downgrade\" data-tweet=\"$AMT - American Tower -2.5% with Raymond James downgrade https://seekingalpha.com/news/3368592-american-towerminus-2_5-raymond-james-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368592-american-towerminus-2_5-raymond-james-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368588\" data-ts=\"1531143454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368588-atlantic-gold-reports-gold-production-and-sales-for-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlantic Gold reports gold production and sales for Q2</a></h4><ul><li>Atlantic Gold&nbsp;<font color='green'>+2.2%</font>&nbsp;pre-market, as the company reports Q2 gold production of 22,269 ounces, with recovery rate of 95.2%.</li><li>Total sales stood at C$35.9M, with sales volume of 22,728 ounces at average sales price of C$1,583</li><li>FY18 production guidance remains unchanged at ~82,000- 90,000ounces.</li><li>Q2 financial results to be announced on August 15, 2018.</li><li><a href=\"http://www.atlanticgoldcorporation.com/_resources/news/nr_2018-07-09.pdf\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3368588\" data-linked=\"Atlantic Gold reports gold production and sales for Q2\" data-tweet=\"Atlantic Gold reports gold production and sales for Q2 https://seekingalpha.com/news/3368588-atlantic-gold-reports-gold-production-and-sales-for-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3368588-atlantic-gold-reports-gold-production-and-sales-for-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368587\" data-ts=\"1531143327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLFS\" target=\"_blank\">BLFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368587-sandler-capital-management-funds-to-buy-500k-shares-in-biolife-stock-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sandler Capital Management funds to buy 500K shares in BioLife; stock up 3%</a></h4><ul><li>BioLife Solutions (<a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a> <font color='green'>+3.2%</font>) <a href=\"https://seekingalpha.com/pr/17210078-sandler-capital-funds-increase-shareholding-biolife-solutions\" target=\"_blank\">announces </a>that two stockholders have agreed to sell 500K common shares to two funds managed by Sander Capital Management in a private placement at an undisclosed price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368587\" data-linked=\"Sandler Capital Management funds to buy 500K shares in BioLife; stock up 3%\" data-tweet=\"$BLFS - Sandler Capital Management funds to buy 500K shares in BioLife; stock up 3% https://seekingalpha.com/news/3368587-sandler-capital-management-funds-to-buy-500k-shares-in-biolife-stock-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3368587-sandler-capital-management-funds-to-buy-500k-shares-in-biolife-stock-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368582\" data-ts=\"1531143046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLT\" target=\"_blank\">PLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368582-plantronics-bull-rings-register-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plantronics bull rings the register; shares down 2%</a></h4><ul><li>The stock's big run higher has now nearly fully reflected the upside from the Polycom purchase, says Sidoti's Gregory Burns, downgrading Plantronics (<a href='https://seekingalpha.com/symbol/PLT' title='Plantronics Inc.'>PLT</a>&nbsp;<font color='red'>-2%</font>) to Neutral from Buy.</li><li>While the cost savings are achievable, investors have to worry at least a little about execution risk.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3367602-plantronics-plus-2_1-percent-closing-polycom-acquisition\" target=\"_blank\">Plantronics +2.1% on closing Polycom acquisition</a> (July 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368582\" data-linked=\"Plantronics bull rings the register; shares down 2%\" data-tweet=\"$PLT - Plantronics bull rings the register; shares down 2% https://seekingalpha.com/news/3368582-plantronics-bull-rings-register-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3368582-plantronics-bull-rings-register-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368580\" data-ts=\"1531142837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKD\" target=\"_blank\">BKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368580-brookdale-up-2-premarket-on-shareholder-letter-citing-value-of-real-estate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookdale up 2% premarket on shareholder letter citing value of real estate</a></h4><ul><li>Brookdale Senior Living (NYSE:<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume on the heels of an <a href=\"https://seekingalpha.com/pr/17210382-land-and-buildings-sends-letter-brookdale-senior-living-shareholders\" target=\"_blank\">open letter</a> to stockholders from institutional shareholder Land and Buildings Investment Management LLC saying the stock could double if and when the market recognizes the value of the company's real estate.</li><li>It also is recommending that management de-stagger the board, refrain from increasing the size of the board, refresh the board with people with healthcare and REIT&nbsp;expertise and reboot the investment committee.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368580\" data-linked=\"Brookdale up 2% premarket on shareholder letter citing value of real estate\" data-tweet=\"$BKD - Brookdale up 2% premarket on shareholder letter citing value of real estate https://seekingalpha.com/news/3368580-brookdale-up-2-premarket-on-shareholder-letter-citing-value-of-real-estate?source=tweet\" data-url=\"https://seekingalpha.com/news/3368580-brookdale-up-2-premarket-on-shareholder-letter-citing-value-of-real-estate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368577\" data-ts=\"1531142522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368577-premarket-losers-of-9-05-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (07/09/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a>&nbsp;<font color='red'>-19%</font>&nbsp;as it flunks late-stage NHL <a href=\"https://seekingalpha.com/news/3368507-cti-bios-pixuvri-flunks-late-stage-nhl-study-shares-halted\" target=\"_blank\">study</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368577\" data-linked=\"Premarket Losers as of 9:05 am (07/09/2018)\" data-tweet=\"$CTIC - Premarket Losers as of 9:05 am (07/09/2018) https://seekingalpha.com/news/3368577-premarket-losers-of-9-05-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368577-premarket-losers-of-9-05-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368570\" data-ts=\"1531142089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368570-tractor-supply-higher-after-stephens-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tractor Supply higher after Stephens upgrade</a></h4><ul> <li>Stephens <a href=\"https://www.stephens.com/institutional-equities-and-research/research/reports/?s=TSCO\" target=\"_blank\">upgrades</a> Tractor Supply (NASDAQ:<a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a>) to an Overweight rating.</li> <li>Tractor Supply is called by Stephens a \"high-quality, unique retailer\" with improving fundamentals.</li> <li>The investment firm lines up a price target of $88 on TSCO to rep 15% upside potential for shares.</li> <li>TSCO <font color='green'>+2.07%</font> premarket to $78.31 vs. a 52-week trading range of $49.87 to $82.68.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3368570\" data-linked=\"Tractor Supply higher after Stephens upgrade\" data-tweet=\"$TSCO - Tractor Supply higher after Stephens upgrade https://seekingalpha.com/news/3368570-tractor-supply-higher-after-stephens-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368570-tractor-supply-higher-after-stephens-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368569\" data-ts=\"1531142064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BNTC\" target=\"_blank\">BNTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368569-premarket-gainers-of-9-05-07-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (07/09/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='green'>+109%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3368500-benitec-inks-gene-therapy-development-deal-axovant-sciences-valued-187_5m\" target=\"_blank\">inks</a> gene therapy development deal with Axovant Sciences valued at up to $187.5M.</li>     <li><a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a> <font color='green'>+42%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3368490-staffing-360-solutions-announces-acquisition-clement-may-uk\" target=\"_blank\">acquisition</a> of Clement May in the UK.</li>     <li><a href='https://seekingalpha.com/symbol/BBOX' title='Black Box Corporation'>BBOX</a> <font color='green'>+32%</font>&nbsp;on biggest <a href=\"https://seekingalpha.com/news/3368421-black-box-doubles-announcing-biggest-deal\" target=\"_blank\">deal</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color='green'>+24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3368492-nano-dimension-partners-aurora-group\" target=\"_blank\">partnering</a> with AURORA Group.</li>     <li><a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3368500-benitec-inks-gene-therapy-development-deal-axovant-sciences-valued-187_5m\" target=\"_blank\">deal</a> with Benitec Biopharma.</li>     <li><a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a> <font color='green'>+15%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3368497-helen-troy-beats-0_41-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3368555-soligenix-receives-european-canadian-patents-ricin-toxin-vaccine-formulation-shares-5_7\" target=\"_blank\">receiving</a> European and Canadian patents for its ricin toxin vaccine formulation.</li>     <li><a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color='green'>+10%</font>&nbsp;on reported sale <a href=\"https://seekingalpha.com/news/3368559-groupon-11-percent-reported-sale-interest\" target=\"_blank\">interest</a>.</li>     <li><a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3368545-fireeye-nearly-5-percent-upgrade\" target=\"_blank\">upgrade</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368569\" data-linked=\"Premarket Gainers as of 9:05 am (07/09/2018)\" data-tweet=\"$BNTC $BNTC $STAF - Premarket Gainers as of 9:05 am (07/09/2018) https://seekingalpha.com/news/3368569-premarket-gainers-of-9-05-07-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3368569-premarket-gainers-of-9-05-07-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368568\" data-ts=\"1531142023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368568-ptc-therapeutics-translarna-shows-treatment-effect-in-younger-dmd-kids-in-mid-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC Therapeutics&#39; Translarna shows treatment effect in younger DMD kids in mid-stage study; shares up 2% premarket</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume on the heels of the <a href=\"https://seekingalpha.com/pr/17210120-ptc-therapeutics-announces-positive-data-translarna-phase-ii-clinical-trial-children-young\" target=\"_blank\">presentation </a>of data from a Phase 2 clinical trial, Study 030, evaluating Translarna in children aged 2-5 years old with Duchenne muscular dystrophy &#40;DMD&#41;. The presentation was delivered at the International Congress on Neuromuscular Diseases in Vienna.</li><li>The results showed improvements in timed function tests and the North Star Ambulatory Assessment from baseline to weeks 28 and 52. Average improvements were as high as 25% after year 1.</li><li>The company says the 28-week data supported the recent positive opinion from the EMA's advisory group CHMP backing the expanded use of Translarna in DMD patients as young as two years of age.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3361047-ema-advisory-group-backs-expanded-label-ptc-therapeutics-translarna\" target=\"_blank\">EMA advisory group backs expanded label for PTC Therapeutics' Translarna</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368568\" data-linked=\"PTC Therapeutics&#39; Translarna shows treatment effect in younger DMD kids in mid-stage study; shares up 2% premarket\" data-tweet=\"$PTCT - PTC Therapeutics&#39; Translarna shows treatment effect in younger DMD kids in mid-stage study; shares up 2% premarket https://seekingalpha.com/news/3368568-ptc-therapeutics-translarna-shows-treatment-effect-in-younger-dmd-kids-in-mid-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3368568-ptc-therapeutics-translarna-shows-treatment-effect-in-younger-dmd-kids-in-mid-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368564\" data-ts=\"1531141612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDE\" target=\"_blank\">CDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368564-couer-mining-reports-strong-q2-production-raises-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Couer Mining reports strong Q2 production, raises full-year guidance</a></h4><ul>     <li>Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>)&nbsp;<font color='green'>+1.7%</font> premarket after announcing <a href=\"https://www.sec.gov/Archives/edgar/data/215466/000021546618000111/a2q18pre-releasexexhibit991.htm\" target=\"_blank\">Q2 production</a> of 3.2M oz. of silver and 94K&nbsp;oz. of gold, or 8.8M silver equiv. oz.</li>     <li>CDE also raises its FY 2018 production guidance to 37.3M-40.5M silver equiv. oz., increasing silver production guidance to 13.2M-14.6M oz. from 12.2M-13.8M oz. and gold production outlook to 360K-380K oz. from its previous view of 355K-375K oz. due to higher grades at its Palmarejo operation in Mexico.</li>     <li>Q2 silver equiv. production at Palmarejo totaled 4.1M oz., up 7% Q/Q, with silver production of 2.1M oz. relatively flat and gold production of 33.7K oz. up by 13%; Y/Y silver and gold production rose 42% and 39%, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368564\" data-linked=\"Couer Mining reports strong Q2 production, raises full-year guidance\" data-tweet=\"$CDE - Couer Mining reports strong Q2 production, raises full-year guidance https://seekingalpha.com/news/3368564-couer-mining-reports-strong-q2-production-raises-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3368564-couer-mining-reports-strong-q2-production-raises-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368559\" data-ts=\"1531141158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368559-groupon-up-11-on-reported-sale-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon up 11% on reported sale interest</a></h4><ul><li>The stock is worth at least $6 per share in a going-private deal, and maybe $12 to a strategic buyer, says DA Davidson bull Tom Forte.</li><li>That management is looking to sell shouldn't be a surprise, he says, as the market isn't properly valuing the stock. The North American business has never been better, says Forte, and the international business is well-positioned.</li><li>Potential buyers (in addition to Alibaba and IAC/InterActive) include: Priceline, Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>), Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>), Qurate Retail Group (NASDAQ:<a href='https://seekingalpha.com/symbol/QRTEA' title='Qurate Retail Group A'>QRTEA</a>)</li><li>He reiterates his Buy rating and $8 price target, with bull-case upside of $12.</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a>&nbsp;<font color='green'>+11.7%</font>&nbsp;premarket to $4.87.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368459-groupon-looking-buyer-recode\" target=\"_blank\">Groupon is looking for a buyer - Recode</a> (July 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3368559\" data-linked=\"Groupon up 11% on reported sale interest\" data-tweet=\"$GOOG $GOOG $GOOGL - Groupon up 11% on reported sale interest https://seekingalpha.com/news/3368559-groupon-up-11-on-reported-sale-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3368559-groupon-up-11-on-reported-sale-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368554\" data-ts=\"1531140362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368554-macau-sector-rallies-focus-turns-to-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau sector rallies as focus turns to Q3</a></h4><ul> <li>Macau casino stocks are higher to start the week after a strong day was put in by the Hong Kong-listed players.</li> <li>Yesterday, Morgan Stanley issued a Q2 forecast for gross gaming revenue of $9.2B (+17% Y/Y, -6% Q/Q), although the firm thinks EBITDA will be pressured by rising labor rates in Macau and a casino win rate below average.</li> <li>Meanwhile, JPMorgan points to \"compelling\" valuations in the sector in its first sector note of Q3.</li> <li>In premarket trading, Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) is <font color='green'>up 3.00%</font>, Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) is <font color='green'>2.33% higher</font> and Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) is showing a <font color='green'>2.50% gain</font>. MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) is <font color='green'>up 1.48%</font>.</li><li>Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>)&nbsp;<font color='green'>rose 5.13%</font>&nbsp;in Hong Kong today and SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>, <a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>)&nbsp;<font color='green'>shot up 9.65%</font>.</li><li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3368554\" data-linked=\"Macau sector rallies as focus turns to Q3\" data-tweet=\"$MLCO $MLCO $WYNN - Macau sector rallies as focus turns to Q3 https://seekingalpha.com/news/3368554-macau-sector-rallies-focus-turns-to-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3368554-macau-sector-rallies-focus-turns-to-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368550\" data-ts=\"1531140160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPRO\" target=\"_blank\">SPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368550-spero-up-10-premarket-on-positive-early-stage-data-on-oral-antibiotic-spr994\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spero up 10% premarket on positive early-stage data on oral antibiotic SPR994</a></h4><ul><li>Thinly traded micro cap Spero Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17209980-spero-announces-positive-interim-phase-1-sad-mad-results-spr994\" target=\"_blank\">announcement </a>of preliminary positive results from its single ascending dose and multiple ascending dose Phase 1 clinical trial of oral carbapenem antibiotic SPR994.</li><li>The company says the data show a favorable safety, pharmacokinetic and pharmacodynamic profile that supports the advancement of SPR994 into Phase 3 development, at a 300 mg dose 3x/day, for the treatment of complicated urinary tract infections (cUTI).</li></ul><div class=\"tiny-share-widget\" data-id=\"3368550\" data-linked=\"Spero up 10% premarket on positive early-stage data on oral antibiotic SPR994\" data-tweet=\"$SPRO - Spero up 10% premarket on positive early-stage data on oral antibiotic SPR994 https://seekingalpha.com/news/3368550-spero-up-10-premarket-on-positive-early-stage-data-on-oral-antibiotic-spr994?source=tweet\" data-url=\"https://seekingalpha.com/news/3368550-spero-up-10-premarket-on-positive-early-stage-data-on-oral-antibiotic-spr994\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368546\" data-ts=\"1531139403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVG\" target=\"_blank\">PVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368546-pretium-resourcesplus-7-brucejack-meets-h1-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pretium Resources +7% as Brucejack meets H1 production guidance</a></h4><ul>     <li>Pretium Resources (NYSE:<a href='https://seekingalpha.com/symbol/PVG' title='Pretium Resources Inc'>PVG</a>) <font color='green'>+7.4%</font> premarket after reporting H1 production at its Brucejack mine in British Columbia of 187K oz. of gold and expecting the mine <a href=\"https://seekingalpha.com/pr/17209805-brucejack-mine-q2-2018-production-update-steady-state-production-achieved\" target=\"_blank\">will produce 200K-220K oz. of gold in H2</a>.</li>     <li>The mine produced more than 111K&nbsp;oz. of gold in Q2, with a gold recovery rate of 97.7% and throughput totaling 237K metric tons of ore milled.</li>     <li>PVG forecasts Brucejack's all-in sustaining costs for H2 of $710-$770/oz. of gold and says it will increase its focus on operational efficiency now that the mine's production has reached steady state.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368546\" data-linked=\"Pretium Resources +7% as Brucejack meets H1 production guidance\" data-tweet=\"$PVG - Pretium Resources +7% as Brucejack meets H1 production guidance https://seekingalpha.com/news/3368546-pretium-resourcesplus-7-brucejack-meets-h1-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3368546-pretium-resourcesplus-7-brucejack-meets-h1-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368545\" data-ts=\"1531139272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368545-fireeye-up-nearly-5-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye up nearly 5% after upgrade</a></h4><ul><li>Demand jumped significantly in Q2 thanks to new pricing strategy and other go-to market changes, says Piper's Andres Nowinski, upgrading FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) to Overweight from Neutral. His $20 price target suggests 25% upside from Friday's close.</li><li>Source: Bloomberg</li><li>Shares&nbsp;<font color='green'>up 4.8%</font>&nbsp;premarket to $16.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368545\" data-linked=\"FireEye up nearly 5% after upgrade\" data-tweet=\"$FEYE - FireEye up nearly 5% after upgrade https://seekingalpha.com/news/3368545-fireeye-up-nearly-5-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3368545-fireeye-up-nearly-5-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368543\" data-ts=\"1531139218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368543-fda-accepts-valeants-marketing-application-for-lower-concentration-gel-for-post-op\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts Valeant&#39;s marketing application for lower concentration gel for post-op inflammation/pain after ocular surgery; shares up 1% premarket</a></h4><ul><li>Valeant Pharmaceuticals (VRX) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17210111-bausch-lomb-announces-u-s-fda-filing-acceptance-loteprednol-etabonate-ophthalmic-gel-0_38\" target=\"_blank\">announcement </a>that the FDA has accepted for review Bausch + Lomb's marketing application seeking approval for its sub-micron loteprednol etabonate ophthalmic gel, 0.38% for the treatment of post-operative pain and inflammation following ocular surgery. The company says the product offers the lowest concentration of loteprednol with less frequent dosing compared to currently available formulations.</li><li>The FDA's action date is February 25, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368543\" data-linked=\"FDA accepts Valeant&#39;s marketing application for lower concentration gel for post-op inflammation/pain after ocular surgery; shares up 1% premarket\" data-tweet=\"$BHC - FDA accepts Valeant&#39;s marketing application for lower concentration gel for post-op inflammation/pain after ocular surgery; shares up 1% premarket https://seekingalpha.com/news/3368543-fda-accepts-valeants-marketing-application-for-lower-concentration-gel-for-post-op?source=tweet\" data-url=\"https://seekingalpha.com/news/3368543-fda-accepts-valeants-marketing-application-for-lower-concentration-gel-for-post-op\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368541\" data-ts=\"1531139068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368541-elaine-wynn-presses-wynn-resorts-board-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elaine Wynn presses Wynn Resorts board again</a></h4><ul> <li>Elaine Wynn is pressing the board at Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) again.</li> <li>She is asking for the board to declassify itself and wants the company to amend its articles of incorporation to be amended in support of annual board elections.</li> <li>Filing statement: \"After observing various actions of the current Board (including the Board&rsquo;s response to Ms. Wynn&rsquo;s good faith efforts to settle differences between Ms. Wynn and the Company) and taking into account the criticisms of the special committee investigation reported on in The Wall Street Journal on June 17, 2018, it is Ms. Wynn&rsquo;s position that the Board needs to have a greater sense of accountability to shareholders, which would be greatly enhanced by an annual election of all directors.\"</li><li><a href=\"https://seekingalpha.com/filing/4094385\" target=\"_blank\">SEC Form 13D</a></li> <li>Shares of Wynn are <font color='green'>up 3.06%</font> in premarket trading to $161.66 amid a broad rally in Macau casino stocks.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368541\" data-linked=\"Elaine Wynn presses Wynn Resorts board again\" data-tweet=\"$WYNN - Elaine Wynn presses Wynn Resorts board again https://seekingalpha.com/news/3368541-elaine-wynn-presses-wynn-resorts-board-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3368541-elaine-wynn-presses-wynn-resorts-board-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368539\" data-ts=\"1531138703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368539-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) assumed with Buy rating and $81 (22% upside) price target at Citigroup. Shares up a fraction premarket.</li><li>Heat Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a>) initiated with Buy rating and $11 (447% upside) price target at Euro Pacific. Shares up&nbsp;<font color='green'>11%</font>&nbsp;premarket.</li><li>MeiraGTx Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MGTX' title='MeiraGTx Holdings plc'>MGTX</a>) initiated with Outperform rating and $21 (64% upside) price target at Evercore ISI. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Sesen Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>) initiated with Buy rating and $5 (158% upside) price target at Canaccord Genuity. Shares up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) initiated with Buy rating at Berenberg.</li><li>Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) upgraded to Outperform at BMO. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Neutral at Citigroup. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>PetMed Express (NASDAQ:<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a>) downgraded to Sell at Craig Hallum. Shares down&nbsp;<font color='red'>2%&nbsp;</font>premarket.</li><li>Dove Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a>) downgraded to Market Perform at Leerink Partners. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket.</li><li>Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) downgraded to Neutral at Citigroup.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368539\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$CVS $CVS $HTBX - Premarket analyst action - healthcare https://seekingalpha.com/news/3368539-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3368539-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368530\" data-ts=\"1531137846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMPH\" target=\"_blank\">KMPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368530-kempharms-kp415-successful-in-late-stage-adhd-study-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KemPharm&#39;s KP415 successful in late-stage ADHD study; shares ahead 7% premarket</a></h4><ul><li>Thinly traded micro cap KemPharm (NASDAQ:<a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm'>KMPH</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/17209923-kempharm-announces-top-line-results-kp415-e01-efficacy-safety-trial-children-adhd\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03292952?intr=kp415&amp;rank=2\" target=\"_blank\">Phase 3 clinical trial</a> assessing KP415 for the treatment of children aged 6-12 years with attention deficit hyperactivity disorder &#40;ADHD&#41;.</li><li>The 150-subject study met the primary endpoint of the change from baseline to day 7 in a scale called SKAMP versus placebo.</li><li>The secondary endpoint of the change from baseline in a scale called PERMP at day 7 compared to placebo was also met.</li><li>The company says it is on track to submit a U.S. marketing application in Q1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368530\" data-linked=\"KemPharm&#39;s KP415 successful in late-stage ADHD study; shares ahead 7% premarket\" data-tweet=\"$KMPH - KemPharm&#39;s KP415 successful in late-stage ADHD study; shares ahead 7% premarket https://seekingalpha.com/news/3368530-kempharms-kp415-successful-in-late-stage-adhd-study-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3368530-kempharms-kp415-successful-in-late-stage-adhd-study-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368525\" data-ts=\"1531137553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HELE\" target=\"_blank\">HELE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368525-helen-of-troyplus-12-after-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helen of Troy +12% after strong quarter</a></h4><ul> <li>Helen of Troy (NASDAQ:<a href='https://seekingalpha.com/symbol/HELE' title='Helen of Troy Limited'>HELE</a>) rallies after the company reports adjusted operating income growth of 30.4% in <a href=\"https://seekingalpha.com/pr/17209884-helen-troy-limited-reports-first-quarter-fiscal-2019-results\" target=\"_blank\">FQ1</a> to $55.5M.</li> <li>\"We continue to see excellent momentum in the business, which led to a strong performance and a great start to our new fiscal year,\" says CEO Julien Mininberg. \"Our strategic choices and ongoing productivity enhancements from the transformation plan are generating healthy results, with consolidated net sales increasing 9.0% and adjusted diluted EPS from continuing operations growing 32.6%,\" he adds.</li> <li>Looking ahead, Helen of Troy expects FY19 sales of $1.485B to $1.510B vs. $1.50B consensus and FY19 EPS of $7.45 to $7.70 vs. $7.42 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3368497-helen-troy-beats-0_41-beats-revenue\" target=\"_blank\">Helen of Troy beats by $0.41, beats on revenue</a> (July 9)</li> <li>HELE <font color='green'>+12.31%</font> premarket to $114.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3368525\" data-linked=\"Helen of Troy +12% after strong quarter\" data-tweet=\"$HELE - Helen of Troy +12% after strong quarter https://seekingalpha.com/news/3368525-helen-of-troyplus-12-after-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3368525-helen-of-troyplus-12-after-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368520\" data-ts=\"1531136888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVX\" target=\"_blank\">BVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368520-bovie-agrees-to-sell-core-business-and-bovie-brand-to-symmetry-surgical-for-97m-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bovie agrees to sell Core business and Bovie brand to Symmetry Surgical for $97M; shares up 10% premarket</a></h4><ul><li>Bovie Medical (NYSEMKT:<a href='https://seekingalpha.com/symbol/BVX' title='Bovie Medical Corporation'>BVX</a>) inks an <a href=\"https://seekingalpha.com/pr/17209957-bovie-medical-corporation-announces-agreement-sell-core-business-segment-symmetry-surgical\" target=\"_blank\">agreement </a>with Specialty Surgical Instrumentation, a subsidiary of Symmetry Surgical, for the sale of its Core business and Bovie brand for $97M in cash.</li><li>Bovie President J. Robert Saron will resign to join Symmetry following the closing of the transaction. It will continue to manage the Core business, providing product and support to customers.</li><li>For Q2, Bovie <a href=\"https://seekingalpha.com/pr/17209954-bovie-medical-corporation-announces-preliminary-second-quarter-2018-revenue-results\" target=\"_blank\">expects revenue</a> of $11.2M - 11.5M. Advanced Energy revenue should be $3.0M - 3.1M while Core revenue should be $7.6M - 7.8M.</li><li>Management will host a conference call this morning at 8:30 am ET to discuss the deal.</li><li>Shares are up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368520\" data-linked=\"Bovie agrees to sell Core business and Bovie brand to Symmetry Surgical for $97M; shares up 10% premarket\" data-tweet=\"$BVX - Bovie agrees to sell Core business and Bovie brand to Symmetry Surgical for $97M; shares up 10% premarket https://seekingalpha.com/news/3368520-bovie-agrees-to-sell-core-business-and-bovie-brand-to-symmetry-surgical-for-97m-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3368520-bovie-agrees-to-sell-core-business-and-bovie-brand-to-symmetry-surgical-for-97m-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3368511\" data-ts=\"1531135825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3368511-pluristem-teams-up-thermo-fisher-to-advance-cell-therapy-manufacturing-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem teams up the Thermo Fisher to advance cell therapy manufacturing; shares up 3% premarket</a></h4><ul><li>Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) is up&nbsp;<font color='green'>3%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17209924-pluristem-signs-collaboration-agreement-thermo-fisher-scientific\" target=\"_blank\">announced collaboration </a>with Thermo Fisher Scientific (NYSE:<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a>) aimed at transforming cell therapy manufacturing into a large-scale industry.</li><li>The partnership will leverage Pluristem's expertise in cell therapy manufacturing, clinical development and quality control with Thermo Fisher's know-how in cell therapy development and bioproduction scaleup.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3368511\" data-linked=\"Pluristem teams up the Thermo Fisher to advance cell therapy manufacturing; shares up 3% premarket\" data-tweet=\"$PSTI $PSTI $TMO - Pluristem teams up the Thermo Fisher to advance cell therapy manufacturing; shares up 3% premarket https://seekingalpha.com/news/3368511-pluristem-teams-up-thermo-fisher-to-advance-cell-therapy-manufacturing-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3368511-pluristem-teams-up-thermo-fisher-to-advance-cell-therapy-manufacturing-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}